553 related articles for article (PubMed ID: 15337038)
21. [Clinical significance of CEA levels in lung cancer].
Noge S; Hara N; Ichinose Y; Ishimatsu T; Motohiro A; Etoh K; Miyake J; Ohta M
Gan No Rinsho; 1985 May; 31(6 Suppl):616-22. PubMed ID: 2993691
[TBL] [Abstract][Full Text] [Related]
22. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
[TBL] [Abstract][Full Text] [Related]
23. [Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms].
Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
Minerva Chir; 1990 Oct; 45(20):1265-72. PubMed ID: 1964495
[TBL] [Abstract][Full Text] [Related]
24. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of pretreatment CEA, SCC-Ag and CA 19-9 levels in sera of patients with non-small cell lung cancer.
Niklinski J; Furman M; Laudanski J; Kozlowski M
Eur J Cancer Prev; 1992 Oct; 1(6):401-6. PubMed ID: 1334443
[TBL] [Abstract][Full Text] [Related]
26. [Clinical evaluation of serum carbohydrate antigen 19-9 in carcinoma of the lung--a comparison with carcinoembryonic antigen].
Hayashibe A; Kodama T; Nishiwaki Y; Kudou H; Inoue Y; Nukariya N; Kaguraoka H; Kuroki M; Takahashi K; Nishiyama Y
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):711-5. PubMed ID: 3030198
[TBL] [Abstract][Full Text] [Related]
27. [Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer].
Fujii M; Kiura K; Kamei H; Segawa Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):452-5. PubMed ID: 2552209
[TBL] [Abstract][Full Text] [Related]
28. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix.
Hopkins MP; Morley GW
Obstet Gynecol; 1991 Jun; 77(6):912-7. PubMed ID: 2030867
[TBL] [Abstract][Full Text] [Related]
29. [Serum neuron specific enolase (NSE) levels in patients with non small cell lung cancer].
Shibayama T; Ohnoshi T; Ueoka H; Horiguchi T; Kodani T; Segawa Y; Maeda T; Miyatake K; Takigawa N; Kimura I
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1097-102. PubMed ID: 1324376
[TBL] [Abstract][Full Text] [Related]
30. [Epidemiologic aspects of the histologic types of lung cancer].
Wilde J; Matthäi C; Wilde J
Z Erkr Atmungsorgane; 1990; 175(1):9-19. PubMed ID: 2171236
[TBL] [Abstract][Full Text] [Related]
31. [Clinical evaluation of combination assay of tumor markers in primary lung cancer patients].
Hatakeyama S; Nagai A; Kioi S; Arakawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Aug; 28(8):1053-8. PubMed ID: 2173801
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of serum levels of beta2-microglobulin and carcino-embryonic antigen in the follow-up of lung cancer (author's transl)].
Ardiet C; Gonthier R; Pasquet P; Lahneche B
Pathol Biol (Paris); 1978 Sep; 26(6):355-7. PubMed ID: 83584
[TBL] [Abstract][Full Text] [Related]
33. [Preoperative high CEA level in lung cancer patients: significant of measurement of serum CEA level among preoperative and postoperative course in long time observed patient].
Takeo S; Hara N; Ohta M
Nihon Kyobu Geka Gakkai Zasshi; 1992 Jul; 40(7):1089-94. PubMed ID: 1506701
[TBL] [Abstract][Full Text] [Related]
34. [Tumor markers. II. Their significance in the follow-up of patients after radical resection of lung neoplasms].
Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
Minerva Chir; 1990 Oct; 45(20):1273-80. PubMed ID: 2082204
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma.
Nikliński J; Furman M; Laudański J; Kozłowski M
Neoplasma; 1992; 39(5):279-82. PubMed ID: 1331826
[TBL] [Abstract][Full Text] [Related]
36. Tumor cell type versus staging in the prognosis of carcinoma of the lung.
Greenberg SD; Fraire AE; Kinner BM; Johnson EH
Pathol Annu; 1987; 22 Pt 2():387-405. PubMed ID: 2825102
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostic significance of carcinoembryonic antigen measurement in bronchial lavage fluids in bronchial carcinoma].
Ma WL
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec; 13(6):349-50, 380-1. PubMed ID: 1964877
[TBL] [Abstract][Full Text] [Related]
38. [The simultaneous evaluation of serum NSE as a tumor marker in lung cancer compared with serum CEA--high sensitivity and specificity defined in the TP-FP curve].
Shimizu K; Nose I; Koga T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):472-8. PubMed ID: 3006595
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemistry in stage FIGO III cervical cancer: prognostic value of tumor associated antigens and intermediate filaments.
Gitsch G; Kainz C; Kohlberger P; Schneider B; Danihel L; Koelbl H; Breitenecker G
Anticancer Res; 1992; 12(6B):2017-9. PubMed ID: 1284198
[TBL] [Abstract][Full Text] [Related]
40. [Clinical investigation of basic fetoprotein (BFP) and carcinoembryonic antigen (CEA) in stomach cancer and lung cancer].
Kanda Y; Ishii M
Gan No Rinsho; 1985 May; 31(6 Suppl):600-5. PubMed ID: 2411961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
